Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prosp...
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The development of resistance by bacterial species is a compelling issue to reconsider indications and administration of antibiotic treatment. Adequate indications and duration of therapy are particularly important for the use of highly potent substances in the intensive care setting. Until recently, no laboratory marker has been available to diffe...
Alternative Titles
Full title
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2717450
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2717450
Other Identifiers
ISSN
1364-8535
E-ISSN
1364-8535,1466-609X
DOI
10.1186/cc7903
